| Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer M Stotz, A Gerger, F Eisner, J Szkandera, H Loibner, A L Ress, P Kornprat, ... British journal of cancer 109 (2), 416-421, 2013 | 521 | 2013 |
| Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients T Gary, M Pichler, K Belaj, F Hafner, A Gerger, H Froehlich, P Eller, P Rief, ... PloS one 8 (7), e67688, 2013 | 365 | 2013 |
| The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer M Stotz, M Pichler, G Absenger, J Szkandera, F Arminger, ... British journal of cancer 110 (2), 435-440, 2014 | 358 | 2014 |
| Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients M Pichler, GC Hutterer, C Stoeckigt, TF Chromecki, T Stojakovic, ... British journal of cancer 108 (4), 901-907, 2013 | 318 | 2013 |
| Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors A Gerger, S Koller, T Kern, C Massone, K Steiger, E Richtig, H Kerl, ... Journal of investigative dermatology 124 (3), 493-498, 2005 | 310 | 2005 |
| The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients S Krenn-Pilko, U Langsenlehner, EM Thurner, T Stojakovic, M Pichler, ... British journal of cancer 110 (10), 2524-2530, 2014 | 299 | 2014 |
| Sensitivity and specificity of confocal laser‐scanning microscopy for in vivo diagnosis of malignant skin tumors A Gerger, S Koller, W Weger, E Richtig, H Kerl, H Samonigg, P Krippl, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 242 | 2006 |
| A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients G Absenger, J Szkandera, M Pichler, M Stotz, F Arminger, ... British journal of cancer 109 (2), 395-400, 2013 | 241 | 2013 |
| Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer F Posch, K Silina, S Leibl, A Mündlein, H Moch, A Siebenhüner, ... Oncoimmunology 7 (2), e1378844, 2018 | 222 | 2018 |
| Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients J Szkandera, M Stotz, G Absenger, T Stojakovic, H Samonigg, P Kornprat, ... British journal of cancer 110 (1), 183-188, 2014 | 206 | 2014 |
| Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing S Mohan, E Heitzer, P Ulz, I Lafer, S Lax, M Auer, M Pichler, A Gerger, ... PLoS genetics 10 (3), e1004271, 2014 | 198 | 2014 |
| Association of BRAF mutations with survival and recurrence in surgically treated patients with metastatic colorectal liver cancer GA Margonis, S Buettner, N Andreatos, Y Kim, D Wagner, K Sasaki, ... JAMA surgery 153 (7), e180996-e180996, 2018 | 193 | 2018 |
| The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas J Szkandera, A Gerger, B Liegl‐Atzwanger, G Absenger, M Stotz, ... International journal of cancer 135 (2), 362-370, 2014 | 183 | 2014 |
| Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection P Ulz, S Perakis, Q Zhou, T Moser, J Belic, I Lazzeri, A Wölfler, A Zebisch, ... Nature communications 10 (1), 4666, 2019 | 174 | 2019 |
| Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients J Szkandera, G Absenger, B Liegl-Atzwanger, M Pichler, M Stotz, ... British journal of cancer 108 (8), 1677-1683, 2013 | 162 | 2013 |
| Influence of sex on the survival of patients with esophageal cancer P Bohanes, D Yang, RS Chhibar, MJ Labonte, T Winder, Y Ning, A Gerger, ... Journal of Clinical Oncology 30 (18), 2265, 2012 | 151 | 2012 |
| The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models Y Ning, MJ Labonte, W Zhang, PO Bohanes, A Gerger, D Yang, ... Molecular cancer therapeutics 11 (6), 1353-1364, 2012 | 127 | 2012 |
| The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients J Szkandera, M Pichler, G Absenger, M Stotz, F Arminger, ... The American Journal of Surgery 208 (2), 210-214, 2014 | 124 | 2014 |
| MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients M Pichler, AL Ress, E Winter, V Stiegelbauer, M Karbiener, ... British journal of cancer 110 (6), 1614-1621, 2014 | 119 | 2014 |
| miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor M Pichler, E Winter, AL Ress, T Bauernhofer, A Gerger, T Kiesslich, S Lax, ... Journal of clinical pathology 67 (3), 198-203, 2014 | 117 | 2014 |
Martin PichlerMedical University of GrazVerified email at medunigraz.at
